Abstract
Worldwide, youth electronic cigarette use (vaping) has risen significantly over the past decade. This public health concern has spurred many high-quality studies characterizing country-specific prevalence, risk factors, physical and behavioral health complications, and optimal methods of assessment and counseling for youth vaping. Clinicians remain underexposed to this recent work, limiting translation of evidence into higher quality patient care. This review aims to provide pediatricians and other clinicians working with youth a clinically focused survey of key research findings and considerations based on recent evidence. This narrative review surveys emerging trends in EC use across different countries, reasons for youth vaping, characteristics of vaping materials that promote youth use, associations with combustible cigarette use, relation with cannabis and other illicit substances, physical and behavioral health risks associated with vaping, and methods of assessment, counseling, and intervention for problematic vaping in youth. Since vaping remains a relatively new phenomenon, long-term health consequences remain unknown.
Conclusion: Youth vaping is an increasingly well-studied phenomenon with both physical and behavioral health risks. Pediatricians and other youth-focused clinicians can apply the lessons of recent research in work with youth and their families.
What is Known: • Youth vaping is an increasingly prevalent public health concern. • Recent research demonstrates physical and behavioral health risks associated with vaping as well as methods for assessment, counseling, and intervention. | |
What is New: • The current review summarizes the latest evidence in a clinically focused framework to facilitate translation of emerging knowledge to practice. |
Similar content being viewed by others
Screening, prevention, and treatment of substance use are core functions of adolescent healthcare [1]. Worldwide, youth electronic cigarette (EC) use, or vaping, has increased substantially over the past decade [2]. ECs are now often the first psychoactive substance used by youth in some settings [3], generating a surge in new research on health consequences of this trend. Adolescent use rates vary across Europe [4], and other countries [5] and clinician beliefs and practices regarding ECs vary considerably across settings [6,7,8].
To consolidate recent data concerning global epidemiology, physical and behavioral health risks, and clinical considerations, we review key facts and considerations for pediatricians based on recent studies, systematic reviews, and guidelines and recommendations. Adolescent vaping practices are ever-evolving, including during the COVID-19 pandemic [9]. To provide best practices in their care, pediatricians must be familiar with the most recent evidence on this global public health concern.
What is vaping and what distinguishes it from conventional cigarette use?
Contemporary ECs were introduced in 2003 by a Chinese inventor and spread to Europe and North America in 2006, initially promoted as a smoking cessation aid in adults [10]. However, ECs have become particularly popular among nicotine-naïve youth, with use reaching epidemic proportions in some areas [11, 12]. EC use became particularly popular among North American adolescents, with rates often exceeding rates of combustible cigarette (CC) use [13]. In Canada, lifetime EC use rates reached 37%, and current use rates reached 14.6% among adolescents in 2018 [13]. In the USA, current use rates reached a peak of 27.5% among high school students in 2019, before decreasing to 19.6% in 2020 (data collected from January through March, prior to the onset of COVID-19 restrictions in the USA) [14]. Among currently using US adolescents, 38.9% reported using at least 20 days per month, and 83% reported use of flavored ECs [14]. EC use has also been popular among UK adolescents, with lifetime use rates of 32.7% and current use rate of 8.9% in 2018, which in contrast to the USA were slightly lower than the CC use rate among UK youth [13]. Limited comparable data exist to make reliable cross-national comparisons of use rates between European countries, although rates generally appear lower than in North America [4]. In a 2016–2017 study among adolescents in seven Western European cities, 35.5% endorsed lifetime EC use (ranging from 23% in Germany to nearly 50% in Italy and Belgium), with 6.6% reporting EC current use (i.e., monthly or more frequently), compared to 17.2% current CC use [4]. Among university students across several Central and Eastern European countries in 2017–2018, while 43.7% reported lifetime use of EC, only 2.9% were current EC users, well below rates of current CC use (12.3%) [15]. South Korean adolescents’ current use rates (3% and 1% among young men and women, respectively) are also comparatively lower and have remained stable from 2016 to 2018 [16]. Restrictiveness of policies around mass marketing and sale to minors has been identified as a factor contributing to differences in EC uptake across locales [5, 17].
ECs are battery-powered devices that contain a liquid that becomes aerosolized when heated, providing nicotine to users with less irritation than CCs [18]. ECs are also known as E-cigs and vape pens and are a type of electronic nicotine delivery systems (ENDS). E-liquids may contain a combination of propylene glycol or glycerin bases, flavoring compounds, nicotine, and/or other psychoactive substances such as cannabis derivates. EC design has evolved from single-use devices that resembled CCs, to rechargeable and refillable “vape pens,” to increasingly personalizable modular products (“pod mods”) [19]. Pod mod devices, initially marketed by JUUL Labs, Inc. and now sold by numerous vaping brands, have become particularly popular among youth. These devices were designed and marketed for their ability to deliver nicotine faster than competing ENDS [13] and can deliver particularly high levels of nicotine [18, 20]. While nicotine concentration in traditional CCs is approximately 1.5–2% (1.5–2 mg/ml) ([21], as cited in [18]), the concentration of nicotine in some pod-based devices is as high as 5%, and daily use of one-quarter of a pod meets the addictive threshold of nicotine [18]. The increased use of high-dose nicotine products has raised alarm among health experts that a new generation may become addicted to nicotine [12].
Why do youth vape?
Youth uptake of ECs has occurred in the context of youth-targeted marketing, social media promotion of ECs, and peer influences. A study of US high school seniors identified three main motivations to vape: taste and entertainment (63%), experimentation (29%), and to replace CCs (7%) [22]. In comparison, a German study found that the vast majority of German youth (aged 14–19) cited curiosity (73.1%) as their reason for EC use, followed by quitting tobacco use (14.9%) and as a complement to tobacco use (7.5%) [23]. In a systematic review of six studies among young adults in varied settings (i.e., USA, Romania, France, New Zealand, and Saudi Arabia), curiosity and EC use by friends were the primary reasons for EC initiation among non-smokers [24]. Among former and current CC users, ECs were used due to perceptions of harm reduction, to aid smoking cessation, to use in smoking-restricted areas, for lower cost compared to CCs, or for flavoring [24]. Studies in Europe and Taiwan have identified male gender, older age, and parental and peer smoking as risk factors for EC use and dual use of ECs and CCs [4, 25, 26].
Some countries have been slow to regulate EC marketing [27], leaving youth vulnerable to advertisers. Advertising has consistently been associated with youths’ intention to use ECs [28]. A systematic review found that in addition to traditional marketing, often utilizing youth-directed strategies, social media platforms have been widely used for public discussion of ECs in a manner that produces largely positive or neutral EC portrayals [29].
Although policy environments seem to account for some cross-country variation in EC use [5, 17], legal restrictions alone do not fully explain variation across countries. For example, Germany has one of the least restrictive nicotine product environments according to the Tobacco Control Scale [30]. Yet, Germany has lower youth EC use rates than Finland and Ireland, two of the most restrictive European countries [30]. These findings demonstrate the need to further study other factors accounting for cross-country variation [4].
Youth EC use is also influenced by the attitudes and behaviors of others around them toward CC use. In Europe, EC use rates have correlated with city-level CC use rates [4]. Peer influence is important [31]. Parent CC use is a risk factor for youth EC use, and parents’ attitudes around EC use influence adolescent use [32]. Certain family systems may have difficulty setting appropriate limits on adolescent access to and use of ECs: In one study, adolescents with divorced parents were 51% more likely to use ECs than those with married parents [33].
Candy or drugs? What youth vape and how they get it
Although ECs are most associated with nicotine, they are a vehicle for substance use that may or may not contain nicotine. In a 2017 nationally representative survey among US adolescents, 25% of current EC users reported vaping only flavoring, while the rest reported vaping nicotine (45%), marijuana (13%), or both (17%) [34]. Among European adolescents who had ever used ECs, 43% reported vaping non-nicotine liquids, 37% nicotine, and 19.6% reported not knowing what they vaped [4].
Many youth may misperceive or do not know what they are vaping. US adolescents commonly misunderstand that nicotine is a tobacco derivative, and those who report vaping only flavoring have been found to have particularly limited knowledge about nicotine use [35]. In one study, 40% of youth reporting use of nicotine-free products had urinary evidence of nicotine [36].
Flavors both attract youth to EC use and perpetuate ongoing use. US adolescents reported more interest in trying ECs offered by a friend if flavored like fruit, candy, or menthol than tobacco [37]. US and UK adolescents have expressed the belief that fruity flavored ECs are less harmful than tobacco-flavored ECs [37, 38]. Adolescents whose first EC is flavored progress to current and more frequent use faster than peers whose initial exposure was unflavored [39], and use of ECs with nontraditional flavors (e.g., candy, fruit) by adolescents was associated with vaping continuation and puffs per use 6 months later compared to traditional flavors (e.g., menthol, tobacco, and flavorless) [40].
Although many locales restrict the sale of ECs to adolescents [27], underage youth find ways of obtaining devices. Most US adolescents who vape own their own device, although they also frequently share devices with peers [41]. One study found that most US youth obtained ECs through online or brick-and-mortar store purchases, while informal purchases, having others purchase for them, or receipt as gifts were less common [41]. In another study, e-liquids were most often obtained by US adolescents through social sources [42]. In a recent study undertaken during the COVID-19 pandemic following heightened regulations in the US surrounding EC marketing, a majority of US youth reported reduction in EC use due to difficulties obtaining EC products. However, youth who continued using ECs shifted toward buying products online, including by receiving deliveries without undergoing age verification [43].
Does vaping lead to, or help prevent, combustible cigarette use?
Many studies have investigated the concern that youth EC use may increase risk for initiation of CCs, threatening to undo decades of progress in reducing population level young adult tobacco use [44]. ECs are being used by youth with a lower risk profile than recent youth CC users: one analysis of nationally representative US data found that only 11–23% of EC-only users would have been predicted by risk factors to be CC users [45].
Additionally, ECs may be an independent risk factor for CC use, suggesting a “gateway effect,” although this remains subject to debate. A meta-analysis of 9 longitudinal studies (n = 17,389) of CC-naïve youth found that EC use was significantly associated with subsequent CC use, even when controlling for known demographic and behavioral risk factors for CC use [46]. A subsequent meta-analysis of 11 studies, though finding the same effect, raised concern that existing evidence remains limited by attrition, publication bias, and inadequate adjustment for confounders [47]. However, studies extensively controlling for smoking risk factors still find ECs independently associated with later CC use [48]. A small longitudinal study found that nicotine doses in ECs were associated with frequency and intensity of subsequent EC and CC use [49]. Among youth who had already experimented with CCs, use of ECs positively associated with progression to current established smoking, suggesting that in youth already starting to use CCs, ECs may contribute to rather than reduce the risk of progression to regular CC use [50].
How does vaping relate to use of marijuana and other substances?
Nicotine affects the neural pathways underlying pleasure and reward and may increase the brain’s long-term sensitivity to other psychoactive substances and drug-seeking behaviors throughout adulthood [51, 52]. In the USA, the surge in EC popularity happened concurrently with a loosening of cannabis regulations, and studies have found that many youth use both ECs and cannabis [3]. A recent US study using cross-sectional data from 2000 to 2019 suggests that adolescents who use cannabis have declining rates of CC use and increasing rates of EC use [53]. In a meta-analysis, the odds of current or past cannabis use were significantly higher among youth who had used ECs, with particularly strong associations among adolescents [3], whose brains are viewed as more vulnerable to addiction than older youth [54]. Three longitudinal studies suggested a temporal relationship in which EC use predates cannabis use [55,56,57], suggesting that addressing EC use is an important means of preventing youth cannabis use and of mitigating the adverse neuropsychological effects of cannabis [58, 59]. Additionally, another meta-analysis found EC use associated with a six-fold risk of alcohol use and binge drinking in adolescents, though most included studies were cross-sectional and did not sufficiently adjust for confounders [60].
What are the physical health risks of vaping?
Although EC aerosols appear less cytotoxic than compounds inhaled during CC use [61], they pose their own physical health risks, especially on the respiratory system [62]. ECs may potentially expose users to heavy metals from batteries and heating coils that may be carcinogenic or toxic to the heart and lungs, though the long-term effects of these exposures among vapers remain unclear [63]. E-liquid bases (e.g., propylene glycol) can be respiratory irritants [64, 65] (see Table 1).
During the summer of 2019, North America underwent an outbreak of EC- or vaping-associated acute lung injury (EVALI). Dozens of deaths and thousands of cases of acute respiratory compromise due to nonspecific acute injury occurred [11]. EVALI was most closely associated with vaping cannabis derivates with vitamin E acetate, which was found present in a large majority of bronchoalveolar lavage samples in one case series of patients with EVALI [66]; however other pathogenic components have also likely contributed [67]. Radiographic findings in adolescents with EVALI include centrilobular ground-glass nodules and ground-glass opacities with subpleural sparing [68].
Additional vaping-related health risks have also been described. Vaping and ingesting e-liquids have been associated with seizures [69]. ECs adversely impact oral health, though possibly less severely than CC [70]. Like CCs, secondhand EC vapor exposure may also pose a health risk and contaminate indoor air quality, although also seemingly less so than secondhand CC smoke [71]. During the COVID-19 pandemic, adolescents may violate social distancing and risk viral exposure as mediated through neurobiologically determined [72] valuation of risks [51]: sharing of vaping devices and mask-free use increases the risk of transmission, increasing the risk of morbidity for the family upon return to home.
How does vaping relate to mental health?
Adults with mental illness suffer disproportionately from tobacco-related morbidity and mortality, and most begin smoking before age 21, making tobacco prevention in young people with mental illness an important priority [74, 75]. Youth with mental illness may be attracted to ECs due to beliefs that ECs may help to modify their psychiatric symptoms, in attempts to offset side effects of psychotropic medications, or due to common underlying risk factors for mental illness and substance use (e.g., executive function deficits) [76, 77]. In a recent systematic review of vaping and mental health comorbidities in youth, vaping has been consistently associated with depression, suicidality, attention-deficit/hyperactivity disorder (ADHD), and conduct disorder in adolescents [76]. Nicotine exposure adversely affects brain development in animal models and increases risk of further substance use [78,78,80] and broader mental illness [81,81,83], as well as problems with learning and memory [84]. Due to a lack of longitudinal studies examining mental health among EC users, it remains unclear to what extent vaping effects the long-term trajectory of psychopathology [76]. Among extant small longitudinal studies in youth, one study suggested a bidirectional relationship between EC use and depressive symptoms [85], while another found that ADHD symptoms predicted onset of EC use but not worsening of ADHD symptoms [86].
Assessment of vaping in youth
Clinicians can most effectively manage the potential risks of EC use on physical health, mental health, and substance use by routinely assessing patients for EC use. Screening tools for youth EC use have not yet been developed and validated, but questions about EC use can be easily integrated into existing assessment methods [87]. The absence of electronic medical record prompts for the assessment of EC use has been identified as an area requiring attention in adolescent primary care visits [88]. Table 2 offers items to consider for assessment based on available evidence [1, 19, 87].
Counseling youth and families about vaping
outh often have misconceptions about vaping, and parents may mistake the possible benefits of ECs among adult smokers [73, 90] for harmlessness in youth. ECs have not been established as an effective intervention for nicotine cessation in youth [90]. Clinicians can provide information about the risks of vaping, while acknowledging that some long-term risks remain unclear. Possible points to discuss with families are listed in Table 3.
Interventions for problematic vaping
Many youth want to quit vaping [89]. At the individual patient level, clinical interventions specific to vaping remain underdeveloped. To date, general principles and established treatments for CC use have been applied. This approach carries potential limitations: a qualitative study of Canadian youth and young adults identified several differences between vaping and CC use that may influence the cessation process [91]. In this study, unlike CC users, EC users reported their enjoyment of flavors as a reason for ongoing use. The convenience and discreetness of vaping (e.g., lack of distinct smell) contribute to ease of EC use throughout the day and in many locations, leading to a lack of awareness of how much they are vaping. Lastly, youth in this study also cited a lack of trusted information about health risks of vaping compared to CCs and greater perceived social acceptability of vaping compared to CC as factors complicating EC cessation.
Like all substance use disorders, clinicians can begin by engaging youth in strength-based motivational interviewing, weighing the risks of vaping against perceived benefits, and identifying specific goals for use reduction or cessation with youth who wish to quit [87]. Youth often cite health, cost, freedom from addiction, social considerations, and academic performance as reasons for wishing to quit vaping [89, 91]. These goals may include eliminating use of favored flavors that although not addictive seem to reinforce use in youth. Social media information and misinformation about EC has caused confusion for some youth that may reduce motivation for cessation [91]; medical professionals can provide credible information about health risks to reinforce motivation for change. Since youth EC users may be less aware of how much they are using (e.g., how many pods per week) than CC users, helping the youth keep a log of use may provide a useful means of developing insight into their use [91]. Clinicians should encourage youth to allow family involvement (e.g., by restricting access to vaping devices, supporting adherence to behavioral goals, and positively reinforcing change) [87]. Parents who smoke should also be referred to smoking cessation resources. When available, individual or group cognitive behavioral therapy for nicotine use can help youth manage symptoms and prevent relapse with good efficacy on quit rates [92]. Mobile apps, such as the “quitSTART” app, can help teens track cessation goals and manage symptoms [93], and text messaging-based programs such as “This is Quitting” have shown effectiveness for facilitating abstinence in a recent randomized trial [94, 95].
Nicotine replacement therapies and bupropion have been found safe and effective in adults, but evidence of effectiveness in adolescents is more limited, and effectiveness seems enhanced when combined with psychosocial interventions [92]. Despite limited evidence for pharmacotherapy, given the relative safety of the medications and the potential harms of nicotine dependence, combination long-acting patch and short-acting as needed gum or lozenges have been recommended for youth under 18 looking to quit vaping [87].
On the population level, school-based interventions, media campaigns, and policy proposals have been proposed to help mitigate EC use [96, 97]. Peer-led network-informed intervention programs show promise [31]. Clinicians can advocate for policies that restrict where vaping products are sold (e.g., banning sales near schools), restrict sales to youth, restrict vaping indoors or in public places, ban advertising, require warning labels on packaging, and ban flavors that are attractive to youth [96, 97].
Conclusion
Youth vaping is now a well-studied phenomenon with various physical and behavioral health risks, some of which differ from traditional smoking. Although vaping-specific treatments remain underdeveloped, pediatricians and other youth clinicians can apply the lessons of recent research to counsel youth and their families and prevent long-term complications of vaping-related nicotine addiction.
Abbreviations
- ADHD:
-
Attention-deficit/hyperactivity disorder
- CC:
-
Combustible cigarette
- EC:
-
Electronic cigarette
- ENDS:
-
Electronic nicotine delivery systems
- EVALI:
-
Electronic cigarette or vaping-associated acute lung injury
References
Michaud P-A, Bélanger R, Mazur A et al (2020) How can primary care practitioners address substance use by adolescents? A position paper of the EUROPEAN academy of PAEDIATRICS. Eur J Pediatr 179:1297–1305. https://doi.org/10.1007/s00431-020-03596-6
Gentzke AS, Creamer M, Cullen KA, et al (2019) Vital Signs: tobacco product use among middle and high school students — United States, 2011–2018. MMWR Morb Mortal Wkly Rep 68:157–164. https://doi.org/10.15585/mmwr.mm6806e1
Chadi N, Schroeder R, Jensen JW, Levy S (2019) Association between electronic cigarette use and marijuana use among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr 173:e192574. https://doi.org/10.1001/jamapediatrics.2019.2574
Kinnunen JM, Rimpelä AH, Lindfors PL et al (2021) Electronic cigarette use among 14- to 17-year-olds in Europe. Eur J Public Health 31:402–408. https://doi.org/10.1093/eurpub/ckaa145
Cho H-J, Dutra LM, Glantz SA (2018) Differences in adolescent e-cigarette and cigarette prevalence in two policy environments: South Korea and the United States. Nicotine Tob Res 20:949–953. https://doi.org/10.1093/ntr/ntx198
Koprivnikar H, Zupanič T, Farkas J (2020) Beliefs and practices regarding electronic cigarettes in smoking cessation among healthcare professionals in Slovenia. Tob Prev Cessat 6:3. https://doi.org/10.18332/tpc/115029
Ferrara P, Shantikumar S, Cabral Veríssimo V et al (2019) Knowledge about e-cigarettes and tobacco harm reduction among public health residents in Europe. Int J Environ Res Public Health 16:2071. https://doi.org/10.3390/ijerph16122071
Erku DA, Gartner CE, Morphett K, Steadman KJ (2020) Beliefs and self-reported practices of health care professionals regarding electronic nicotine delivery systems: a mixed-methods systematic review and synthesis. Nicotine Tob Res 22:619–629
Dumas TM, Ellis W, Litt DM (2020) What does adolescent substance use look like during the COVID-19 pandemic? Examining changes in frequency, social contexts, and pandemic-related predictors. J Adolesc Heal 67:354–361. https://doi.org/10.1016/j.jadohealth.2020.06.018
CASAA (2012) E-cigarette history: a historical timeline of electronic cigarettes. In: Consum. Advocates Smokefree Altern. Assoc. https://casaa.org/education/vaping/historical-timeline-of-electronic-cigarettes/. Accessed 28 Feb 2021
King BA, Jones CM, Baldwin GT, Briss PA (2020) The EVALI and youth vaping epidemics — implications for Public Health. N Engl J Med 382:689–691. https://doi.org/10.1056/nejmp1916171
Besaratinia A, Tommasi S (2020) Vaping epidemic: challenges and opportunities. Cancer Causes Control 31:663–667. https://doi.org/10.1007/s10552-020-01307-y
Hammond D, Reid JL, Rynard VL, et al (2019) Prevalence of vaping and smoking among adolescents in Canada, England, and the United States: repeat national cross sectional surveys. BMJ 365:12219. https://doi.org/10.1136/bmj.l2219
Wang TW, Neff LJ, Park-Lee E, et al (2020) E-cigarette use among middle and high school students — United States, 2020. MMWR Morb Mortal Wkly Rep 69:1310–1312. https://doi.org/10.15585/mmwr.mm6937e1
Brożek GM, Jankowski M, Lawson KA, et al 2019 The prevalence of cigarette and e-cigarette smoking among students in central and eastern Europe-results of the YUPESS study. Int J Environ Res Public Health 16:2297. https://doi.org/10.3390/ijerph16132297
Lee ES, Paek YJ (2020) Prevalence and correlates of the dual use of conventional and electronic cigarettes among Korean adolescents: 2016–2018 Korean youth risk behavior survey. J Korean Soc Res Nicotine Tob 11:64–74. https://doi.org/10.25055/JKSRNT.2020.11.2.64
Hammond D, Reid JL, Burkhalter R, Rynard VL (2020) E-cigarette marketing regulations and youth vaping: cross-sectional surveys, 2017–2019. Pediatrics 146:e20194020. https://doi.org/10.1542/peds.2019-4020
Jackler RK, Ramamurthi D (2019) Nicotine arms race: JUUL and the high-nicotine product market. Tob Control 28:623–628. https://doi.org/10.1136/tobaccocontrol-2018-054796
Ker S, Peckham E, Gilbody S, Bonner S (2019) Everything you wanted to know about e-cigarettes and vaping but were afraid to ask: a guide for mental health clinicians. BJPsych Adv 25:279–286. https://doi.org/10.1192/bja.2019.36
Goniewicz ML, Boykan R, Messina CR et al (2019) High exposure to nicotine among adolescents who use Juul and other vape pod systems (‘pods’). Tob Control 28:676–677. https://doi.org/10.1136/tobaccocontrol-2018-054565
Benowitz NL, Henningfield JE (1994) Establishing a nicotine threshold for addiction – the implications for tobacco regulation. N Engl J Med 331:123–125. https://doi.org/10.1056/NEJM199407143310212
Evans-Polce RJ, Patrick ME, Lanza ST et al (2018) Reasons for vaping among U.S. 12th Graders. J Adolesc Health 62:457–462. https://doi.org/10.1016/j.jadohealth.2017.10.009
Eichler M, Blettner M, Singer S (2016) The use of e-cigarettes. Dtsch Aerzteblatt Online. 113:847-854. https://doi.org/10.3238/arztebl.2016.0847
Kinouani S, Leflot C, Vanderkam P et al (2020) Motivations for using electronic cigarettes in young adults: a systematic review. Subst Abus 41:315–322
Hanewinkel R, Isensee B (2015) Risk factors for e-cigarette, conventional cigarette, and dual use in German adolescents: a cohort study. Prev Med (Baltim) 74:59–62. https://doi.org/10.1016/j.ypmed.2015.03.006
Chen P-C, Chang L-C, Hsu C, Lee Y-C (2019) Dual use of e-cigarettes and traditional cigarettes among adolescents in Taiwan, 2014–2016. Nicotine Tob Res 21:48–54. https://doi.org/10.1093/ntr/nty003
Kennedy RD, Awopegba A, De León E, Cohen JE (2017) Global approaches to regulating electronic cigarettes. Tob Control 26:440–445. https://doi.org/10.1136/tobaccocontrol-2016-053179
Amin S, Dunn AG, Laranjo L (2020) Social influence in the uptake and use of electronic Cigarettes: a systematic review. Am J Prev Med 58:129–141. https://doi.org/10.1016/j.amepre.2019.08.023
Collins L, Glasser AM, Abudayyeh H et al (2019) E-cigarette marketing and communication: how e-cigarette companies market e-cigarettes and the public engages with e-cigarette information. Nicotine Tob Res 21:14–24
Joossens L, Feliu A, Fernandez E. The Tobacco Control Scale 2019 in Europe. Brussels: Association of European Cancer Leagues, Catalan Institute of Oncology; 2020. Available from: http://www.tobaccocontrolscale.org/TCS2019.pdf
Wyman PA, Rulison K, Pisani AR et al (2021) Above the influence of vaping: Peer leader influence and diffusion of a network-informed preventive intervention. Addict Behav 113:106693. https://doi.org/10.1016/j.addbeh.2020.106693
Trucco EM, Cristello JV, Sutherland MT (2021) Do parents still matter? The impact of parents and peers on adolescent electronic cigarette use. J Adolesc Heal 68:780–786. https://doi.org/10.1016/j.jadohealth.2020.12.002
Watkins NK, Ohannessian CMC (2020) Timing of vape use among adolescents: differences by family structure. Drug Alcohol Depend 209:107953. https://doi.org/10.1016/j.drugalcdep.2020.107953
Dai H, Siahpush M (2020) Use of e-cigarettes for nicotine, marijuana, and just flavoring among U.S. Youth Am J Prev Med 58:244–249. https://doi.org/10.1016/j.amepre.2019.09.006
Pepper JK, Farrelly MC, Watson KA (2018) Adolescents’ understanding and use of nicotine in e-cigarettes. Addict Behav 82:109–113. https://doi.org/10.1016/j.addbeh.2018.02.015
Boykan R, Messina CR, Chateau G et al (2019) Self-reported use of tobacco, E-cigarettes, and marijuana versus urinary biomarkers. Pediatrics 143:e20183531. https://doi.org/10.1542/peds.2018-3531
Pepper JK, Ribisl KM, Brewer NT (2016) Adolescents’ interest in trying flavoured e-cigarettes. Tob Control 25:ii62–ii66. https://doi.org/10.1136/tobaccocontrol-2016-053174
Ford A, MacKintosh AM, Bauld L et al (2016) Adolescents’ responses to the promotion and flavouring of e-cigarettes. Int J Public Health 61:215–224. https://doi.org/10.1007/s00038-015-0769-5
Audrain-McGovern J, Rodriguez D, Pianin S, Alexander E (2019) Initial e-cigarette flavoring and nicotine exposure and e-cigarette uptake among adolescents. Drug Alcohol Depend 202:149–155. https://doi.org/10.1016/j.drugalcdep.2019.04.037
Leventhal AM, Goldenson NI, Cho J et al (2019) Flavored e-cigarette use and progression of vaping in adolescents. Pediatrics 144:e20190789. https://doi.org/10.1542/peds.2019-0789
Pepper JK, Coats EM, Nonnemaker JM, Loomis BR (2019) How do adolescents get their e-cigarettes and other electronic vaping devices? Am J Heal Promot 33:420–429. https://doi.org/10.1177/0890117118790366
McKeganey N, Russell C, Katsampouris E, Haseen F (2019) Sources of youth access to JUUL vaping products in the United States. Addict Behav Reports 10:100232. https://doi.org/10.1016/j.abrep.2019.100232
Gaiha SM, Lempert LK, Halpern-Felsher B (2020) Underage youth and young adult e-cigarette use and access before and during the coronavirus disease 2019 pandemic. JAMA Netw Open 3:e2027572. https://doi.org/10.1001/jamanetworkopen.2020.27572
Pierce JP, Chen R, Leas EC et al (2021) Use of e-cigarettes and other tobacco products and progression to daily cigarette smoking. Pediatrics 147:e2020025122. https://doi.org/10.1542/peds.2020-025122
Dutra LM, Glantz SA (2017) E-cigarettes and national adolescent cigarette use: 2004–2014. Pediatrics 139:e20162450. https://doi.org/10.1542/peds.2016-2450
Soneji S, Barrington-Trimis JL, Wills TA et al (2017) Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults. JAMA Pediatr 171:788. https://doi.org/10.1001/jamapediatrics.2017.1488
Chan GCK, Stjepanović D, Lim C, et al (2020) Gateway or common liability? A systematic review and meta-analysis of studies of adolescent e-cigarette use and future smoking initiation. Addiction 116:743-756. https://doi.org/10.1111/add.15246
Epstein M, Bailey JA, Kosterman R, et al (2020) E-cigarette use is associated with subsequent cigarette use among young adult non-smokers, over and above a range of antecedent risk factors: a propensity score analysis. Addiction add.15317. https://doi.org/10.1111/add.15317
Goldenson NI, Leventhal AM, Stone MD et al (2017) Associations of electronic cigarette nicotine concentration with subsequent cigarette smoking and vaping levels in adolescents. JAMA Pediatr 171:1192. https://doi.org/10.1001/jamapediatrics.2017.3209
Chaffee BW, Watkins SL, Glantz SA (2018) Electronic cigarette use and progression from experimentation to established smoking. Pediatrics 141:e20173594. https://doi.org/10.1542/peds.2017-3594
Casey BJ, Jones RM (2010) Neurobiology of the adolescent brain and behavior: Implications for substance use disorders. J Am Acad Child Adolesc Psychiatry 49:1189–1201
Ren M, Lotfipour S (2019) Nicotine gateway effects on adolescent substance use. West J Emerg Med 20:696–709. https://doi.org/10.5811/westjem.2019.7.41661
Terry-McElrath YM, O’Malley PM, Johnston LD (2020) Changes in the order of cigarette and marijuana initiation and associations with cigarette use, nicotine vaping, and marijuana use: U.S. 12th Grade Students, 2000–2019. Prev Sci 21:960–971. https://doi.org/10.1007/s11121-020-01150-2
Gray KM, Squeglia LM (2018) Research review: what have we learned about adolescent substance use? J Child Psychol Psychiatry Allied Discip 59:618–627
Unger JB, Soto DW, Leventhal A (2016) E-cigarette use and subsequent cigarette and marijuana use among Hispanic young adults. Drug Alcohol Depend 163:261–264. https://doi.org/10.1016/j.drugalcdep.2016.04.027
Dai H, Catley D, Richter KP et al (2018) Electronic cigarettes and future marijuana use: a longitudinal study. Pediatrics 141:e20173787. https://doi.org/10.1542/peds.2017-3787
Audrain-Mcgovern J, Stone MD, Barrington-Trimis J et al (2018) Adolescent e-cigarette, hookah, and conventional cigarette use and subsequent marijuana use. Pediatrics 142:e20173616. https://doi.org/10.1542/peds.2017-3616
Bagot KS, Milin R, Kaminer Y (2015) Adolescent initiation of cannabis use and early-onset psychosis. Subst Abus 36:524–533
Meier MH, Caspi A, Ambler A et al (2012) Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A 109:E2657–E2664. https://doi.org/10.1073/pnas.1206820109
Rothrock AN, Andris H, Swetland SB et al (2020) Association of e-cigarettes with adolescent alcohol use and binge drinking-drunkenness: a systematic review and meta-analysis. Am J Drug Alcohol Abuse 46:684–698. https://doi.org/10.1080/00952990.2020.1771723
Farsalinos KE, Romagna G, Allifranchini E, et al. Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health. 2013;10(10):5146–5162.
Hamberger ES, Halpern-Felsher B (2020) Vaping in adolescents. Curr Opin Pediatr 32:378–383. https://doi.org/10.1097/MOP.0000000000000896
Gaur S, Agnihotri R (2019) Health effects of trace metals in electronic cigarette aerosols—a systematic review. Biol Trace Elem Res 188:295–315
Ratajczak A, Feleszko W, Smith DM, Goniewicz M (2018) How close are we to definitively identifying the respiratory health effects of e-cigarettes? Expert Rev Respir Med 12:549–556. https://doi.org/10.1080/17476348.2018.1483724
Marini S, Buonanno G, Stabile L, Ficco G (2014) Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide. Toxicol Appl Pharmacol 278:9–15. https://doi.org/10.1016/j.taap.2014.04.004
Blount BC, Karwowski MP, Shields PG et al (2020) Vitamin e acetate in bronchoalveolar-lavage fluid associated with EVALI. N Engl J Med 382:697–705. https://doi.org/10.1056/NEJMoa1916433
Jonas AM, Raj R (2020) Vaping-related acute parenchymal lung injury: a systematic review. Chest 158:1555–1565
Thakrar PD, Boyd KP, Swanson CP et al (2020) E-cigarette, or vaping, product use-associated lung injury in adolescents: a review of imaging features. Pediatr Radiol 50:338–344. https://doi.org/10.1007/s00247-019-04572-5
Faulcon LM, Rudy S, Limpert J et al (2020) Adverse experience reports of seizures in youth and young adult electronic nicotine delivery systems users. J Adolesc Heal 66:15–17. https://doi.org/10.1016/j.jadohealth.2019.10.002
Yang I, Sandeep S, Rodriguez J (2020) The oral health impact of electronic cigarette use: a systematic review. Crit Rev Toxicol 50:97–127. https://doi.org/10.1080/10408444.2020.1713726
Hess IMR, Lachireddy K, Capon A (2016) A systematic review of the health risks from passive exposure to electronic cigarette vapour. Public Heal Res Pract 26:e2621617. https://doi.org/10.17061/phrp2621617
Casey BJ, Jones RM, Somerville LH (2011) Braking and accelerating of the adolescent brain. J Res Adolesc 21:21–33. https://doi.org/10.1111/j.1532-7795.2010.00712.x
Hajek P, Phillips-Waller A, Przulj D et al (2019) A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med 380:629–637. https://doi.org/10.1056/nejmoa1808779
Williams JM, Steinberg ML, Griffiths KG, Cooperman N (2013) Smokers with behavioral health comorbidity should be designated a tobacco use disparity group. Am J Public Health 103:1549–1555. https://doi.org/10.2105/AJPH.2013.301232
Prochaska JJ, Das S, Young-Wolff KC (2017) Smoking, mental illness, and public health. Annu Rev Public Health 38:165–185. https://doi.org/10.1146/annurev-publhealth-031816-044618
Becker TD, Arnold MK, Ro V et al (2020) Systematic review of electronic cigarette use (vaping) and mental health comorbidity among adolescents and young adults. Nicotine Tob Res 23:415–425. https://doi.org/10.1093/ntr/ntaa171
Pentz MA, Shin H, Riggs N et al (2015) Parent, peer, and executive function relationships to early adolescent e-cigarette use: a substance use pathway? Addict Behav 42:73–78. https://doi.org/10.1016/j.addbeh.2014.10.040
Lai S, Lai H, Page JB, McCoy CB (2000) The association between cigarette smoking and drug abuse in the United States. J Addict Dis 19:11–24. https://doi.org/10.1300/J069v19n04_02
Kandel D, Kandel E (2015) The gateway hypothesis of substance abuse: developmental, biological and societal perspectives. Acta Paediatr 104:130–137. https://doi.org/10.1111/apa.12851
Degenhardt L, Dierker L, Chiu WT et al (2010) Evaluating the drug use “gateway” theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug Alcohol Depend 108:84–97. https://doi.org/10.1016/j.drugalcdep.2009.12.001
Yuan M, Cross SJ, Loughlin SE, Leslie FM (2015) Nicotine and the adolescent brain. J Physiol 593:3397–3412. https://doi.org/10.1113/JP270492
Goriounova NA, Mansvelder HD (2012) Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function. Cold Spring Harb Perspect Med 2:a012120–a012120. https://doi.org/10.1101/cshperspect.a012120
Smith RF, McDonald CG, Bergstrom HC et al (2015) Adolescent nicotine induces persisting changes in development of neural connectivity. Neurosci Biobehav Rev 55:432–443. https://doi.org/10.1016/j.neubiorev.2015.05.019
Slotkin TA (2002) Nicotine and the adolescent brain: insights from an animal model. Neurotoxicol Teratol 24:369–384. https://doi.org/10.1016/S0892-0362(02)00199-X
Lechner WV, Janssen T, Kahler CW et al (2017) Bi-directional associations of electronic and combustible cigarette use onset patterns with depressive symptoms in adolescents. Prev Med (Baltim) 96:73-78. https://doi.org/10.1016/j.ypmed.2016.12.034
Dvorsky MR, Langberg JM (2019) Cigarette and e-cigarette use and social perceptions over the transition to college: The Role of ADHD Symptoms. Psychol Addict Behav 33:318-330. https://doi.org/10.1037/adb0000450
Hadland SE, Chadi N (2020) Through the haze: what clinicians can do to address youth VAPING. J Adolesc Heal 66:10–14. https://doi.org/10.1016/j.jadohealth.2019.10.009
LeLaurin JH, Theis RP, Thompson LA et al (2020) Tobacco-related counseling and documentation in adolescent primary care practice: challenges and opportunities. Nicotine Tob Res 22:1023–1029. https://doi.org/10.1093/ntr/ntz076
Amato MS, Bottcher MM, Cha S et al (2021) “It’s really addictive and I’m trapped:” a qualitative analysis of the reasons for quitting vaping among treatment-seeking young people. Addict Behav 112:106599. https://doi.org/10.1016/j.addbeh.2020.106599
Hartmann-Boyce J, McRobbie H, Lindson N et al (2021) Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD010216.pub5
Sanchez S, Kaufman P, Pelletier H et al (2021) Is vaping cessation like smoking cessation? A qualitative study exploring the responses of youth and young adults who vape e-cigarettes. Addict Behav 113:106687. https://doi.org/10.1016/j.addbeh.2020.106687
Cavallo DA, Krishnan-Sarin S (2019) Nicotine use disorders in adolescents. Pediatr Clin North Am 66:1053–1062. https://doi.org/10.1016/j.pcl.2019.08.002
US Department of Health and Human Services. (2021). quitSTART. https://smokefree.gov/tools-tips/apps/quitstart. Accessed 31 July 2021.
Graham AL, Jacobs MA, Amato MS (2020) Engagement and 3-month outcomes from a digital e-cigarette cessation program in a cohort of 27 000 teens and young adults. Nicotine Tob Res 22:859–860. https://doi.org/10.1093/ntr/ntz097
Graham AL, Amato MS, Cha S et al (2021) Effectiveness of a vaping cessation text message program among young adult e-cigarette users: a randomized clinical trial. JAMA Intern Med 181:923-930. https://doi.org/10.1001/jamainternmed.2021.1793
Al-Hamdani M, Hopkins DB, Park T (2020) Vaping among youth and young adults: a “red alert” state. J Public Health Policy 41:63–69. https://doi.org/10.1057/s41271-019-00193-2
Substance Abuse and Mental Health Services Administration (SAMHSA): (2020) Reducing vaping among youth and young adults. SAMHSA Publication No. PEP20–06–01–003.
Kosmider L, Sobczak A, Fik M et al (2014) Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res 16:1319–1326. https://doi.org/10.1093/ntr/ntu078
Abeles M, Popofsky S, Wen A et al (2020) Vaping-associated lung injury caused by inhalation of cannabis oil. Pediatr Pulmonol 55:226–228. https://doi.org/10.1002/ppul.24579
Jackson DB, Boccio CM, Leal WE, Vaughn MG (2019) It’s all the rage! Exploring the nuances in the link between vaping and adolescent delinquency. J Crim Justice 63:58–69. https://doi.org/10.1016/j.jcrimjus.2019.04.004
Schillo BA, Cuccia AF, Patel M, et al (2020) JUUL in school: teacher and administrator awareness and policies of e-cigarettes and JUUL in U.S. Middle and High Schools. Health Promot Pract 21:20-24. https://doi.org/10.1177/1524839919868222
Allem J-P, Dharmapuri L, Unger JB, Cruz TB (2018) Characterizing JUUL-related posts on Twitter. Drug Alcohol Depend 190:1–5. https://doi.org/10.1016/j.drugalcdep.2018.05.018
Kavuluru R, Han S, Hahn EJ (2019) On the popularity of the USB flash drive-shaped electronic cigarette Juul. Tob. Control 28:110–112. https://doi.org/10.1136/tobaccocontrol-2018-054259
Centers for Disease Control and Prevention (2020) Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html. Accessed 3 Mar 2021.
Rossheim ME, Livingston MD, Soule EK et al (2019) Electronic cigarette explosion and burn injuries, US Emergency Departments 2015–2017. Tob Control 28:472–474. https://doi.org/10.1136/tobaccocontrol-2018-054518
Kumetz EA, Hurst ND, Cudnik RJ, Rudinsky SL (2016) Electronic cigarette explosion injuries. Am J Emerg Med 34:2252.e1-2252.e3. https://doi.org/10.1016/j.ajem.2016.04.010
Cho JH, Shin E, Moon S-S (2011) Electronic-cigarette smoking experience among adolescents. J Adolesc Heal 49:542–546. https://doi.org/10.1016/j.jadohealth.2011.08.001
Author information
Authors and Affiliations
Contributions
TDB: Developed idea and strategy and wrote first draft of paper. TRR: Participated in the development of the idea and design, co-wrote and revised the article, checked all the processes of the article.
Corresponding authors
Ethics declarations
Ethics approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare no competing interests.
Additional information
Communicated by Nicole Ritz.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Becker, T.D., Rice, T.R. Youth vaping: a review and update on global epidemiology, physical and behavioral health risks, and clinical considerations. Eur J Pediatr 181, 453–462 (2022). https://doi.org/10.1007/s00431-021-04220-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-021-04220-x